Skip to main content

Table 1 Baseline and 4-month follow-up characteristics of the Sham-VNS and VNS groups

From: Chronic vagus nerve stimulation for drug-resistant epilepsy may influence fasting blood glucose concentration

VariablesSham-VNS, n = 13VNS, n = 19p1p2p3
Baseline4 monthsBaseline4 months
Height (cm)162 ± 16163 ± 15155 ± 23157 ± 210.7000.0410.009
Body weight (kg)60.9 ± 20.461.1 ± 19.255.6 ± 20.857.1 ± 21.00.2820.6850.065
BMI (kg/m2)22.3 ± 3.922.2 ± 3.722.2 ± 4.222.3 ± 4.31.0000.8140.199
Systolic blood pressure (mmHg)116 ± 21114 ± 13115 ± 14115 ± 120.7880.6660.896
Diastolic blood pressure (mmHg)73 ± 1174 ± 876 ± 1178 ± 100.8470.9440.081
  1. p values were provided for comparison as follows: (1) p1: Sham-VNS vs. VNS at baseline; (2) p2: Baseline vs. 4-month follow-up for Sham-VNS group; (3) p3: Baseline vs. 4-month follow-up for VNS group